An anti-CRISPR from a virulent streptococcal phage inhibits Streptococcus pyogenes Cas9

Alexander P Hynes1, Geneviève M Rousseau1, Marie-Laurence Lemay1

  • 1Département de biochimie, de microbiologie, et de bioinformatique, Faculté des sciences et de génie, Groupe de recherche en écologie buccale, Faculté de médecine dentaire, Université Laval, Québec City, QC, G1V 0A6, Canada.

Nature Microbiology
|August 9, 2017
PubMed

Insights

Researchers discovered a novel anti-CRISPR (Acr) protein in a virulent phage that effectively disables CRISPR-Cas immunity in bacteria. This finding expands the known diversity of Acrs and offers new tools for controlling genome editing.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Background:

  • The CRISPR-Cas system, derived from prokaryotic immunity, is a powerful genome-editing tool.
  • Bacterial viruses (phages) can evade CRISPR-Cas immunity through various mechanisms, including anti-CRISPR (Acr) proteins.
  • Existing Acrs originate from temperate phages or genomic elements and share common properties.

Purpose of the Study:

  • To identify novel anti-CRISPR (Acr) proteins from virulent phages.
  • To characterize the mechanism and scope of activity of a newly identified Acr.
  • To explore the biotechnological potential of Acrs as off-switches for CRISPR-Cas genome editing.

Main Methods:

  • Challenged a Streptococcus thermophilus strain with CRISPR immunity against virulent phages.
  • Identified a phage exhibiting exceptionally high evasion rates (>40,000×).
  • Systematically cloned phage genes to pinpoint the specific Acr responsible for immunity abolition and tested its activity in different strains and bacterial genera using the SpCas9 system.

Main Results:

  • A novel, unrelated Acr was identified in a virulent phage infecting Streptococcus thermophilus.
  • This Acr was solely responsible for abolishing CRISPR-Cas immunity in the tested strain.
  • The Acr demonstrated activity in a different S. thermophilus strain, against unrelated phages, and effectively disabled SpCas9-mediated immunity in another bacterial genus.

Conclusions:

  • A new class of anti-CRISPR (Acr) protein has been discovered in a virulent phage, distinct from previously characterized Acrs.
  • This Acr represents a significant expansion of the known anti-CRISPR repertoire and their evolutionary origins.
  • The identified Acr completely inhibits SpCas9 activity, highlighting its potential as a controllable 'off switch' for CRISPR-based genome editing applications.

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.1K
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.3K
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.2K
The Antiviral System of Bacteria and Archaea: CRISPR01:23

The Antiviral System of Bacteria and Archaea: CRISPR

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
804
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
64.2K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.9K